College of Medicine names international scholar new vice-dean of research at U of S
SASKATOON - Highly regarded academic and researcher Dr. Marek Radomski has been appointed vice-dean, research for the University of Saskatchewan's (U of S) College of Medicine for a five-year term beginning March 14, 2016.
"Raising the profile of health research in the college has been a priority for me since my arrival," said Dr. Preston Smith, dean of the College of Medicine. "Dr. Radomski brings with him an international research reputation and a wealth of experience that will help propel the college's research agenda forward."
Radomski is a highly-cited pharmacologist who has had an extensive career in both academia and the pharmaceutical industry. His expertise has taken him to Poland, the United Kingdom, the United States, Spain, Canada, and to his current post in Ireland. Since 2006, he has been with the School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin as professor, chair of pharmacology, director of Trinity Cancer Drug Discovery Centre and head of the school.
His research focuses on pharmacology, nanomedicine, nanopharmacology and nanodiagnostics of cardiovascular diseases and cancer.
"I am honored and delighted to be appointed as the first vice-dean, research in the College of Medicine and I will work very hard to stimulate its research fortunes," said Radomski.
Radomski trained at the Copernicus Academy of Medicine in Krakow, Poland, earning his MD in 1978, followed by his PhD in pharmacology in 1983. He earned his DSc from the Medical Research Centre, Polish Academy of Sciences in 1990. He moved to Canada in 1994 and was Alberta Heritage Foundation for Medical Research scholar and scientist of the Canadian Institutes of Health Research. In 2005, he was named a Fellow of the World Innovation Foundation and in 2008 he received an honorary degree, doctor honoris causa degree, from the Complutense University in Madrid, Spain. He trained many PhD students and postdoctoral fellows and serves as a reviewer and editor for multiple scientific journals including Nature, The Lancet, PNAS, Nanomedicine (Lond.) and International Journal of Nanomedicine.
Radomski's appointment comes after an extensive international search. Radomski will replace Stephan Milosavljevic, who has served as acting vice-dean, research since May 1, 2015.
"Stephan has provided exemplary vision and leadership while in this role," said Smith. "The work he has done as acting vice-dean will place Dr. Radomski in a position to succeed upon stepping in."
Dr. Radomski is available for telephone interviews from 9 am to 2 pm on Jan 20 and 21. A photo is available upon request.
To arrange an interview, contact:
James Shewaga
Media Relations Specialist
University of Saskatchewan
306-966-1851
james.shewaga@usask.ca
Radomski is a highly-cited pharmacologist who has had an extensive career in both academia and the pharmaceutical industry. His expertise has taken him to Poland, the United Kingdom, the United States, Spain, Canada, and to his current post in Ireland. Since 2006, he has been with the School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin as professor, chair of pharmacology, director of Trinity Cancer Drug Discovery Centre and head of the school.
His research focuses on pharmacology, nanomedicine, nanopharmacology and nanodiagnostics of cardiovascular diseases and cancer.
"I am honored and delighted to be appointed as the first vice-dean, research in the College of Medicine and I will work very hard to stimulate its research fortunes," said Radomski.
Radomski trained at the Copernicus Academy of Medicine in Krakow, Poland, earning his MD in 1978, followed by his PhD in pharmacology in 1983. He earned his DSc from the Medical Research Centre, Polish Academy of Sciences in 1990. He moved to Canada in 1994 and was Alberta Heritage Foundation for Medical Research scholar and scientist of the Canadian Institutes of Health Research. In 2005, he was named a Fellow of the World Innovation Foundation and in 2008 he received an honorary degree, doctor honoris causa degree, from the Complutense University in Madrid, Spain. He trained many PhD students and postdoctoral fellows and serves as a reviewer and editor for multiple scientific journals including Nature, The Lancet, PNAS, Nanomedicine (Lond.) and International Journal of Nanomedicine.
Radomski's appointment comes after an extensive international search. Radomski will replace Stephan Milosavljevic, who has served as acting vice-dean, research since May 1, 2015.
"Stephan has provided exemplary vision and leadership while in this role," said Smith. "The work he has done as acting vice-dean will place Dr. Radomski in a position to succeed upon stepping in."
-30-
Dr. Radomski is available for telephone interviews from 9 am to 2 pm on Jan 20 and 21. A photo is available upon request.
To arrange an interview, contact:
James Shewaga
Media Relations Specialist
University of Saskatchewan
306-966-1851
james.shewaga@usask.ca